Pharmaceuticals: State of the Industry Report

What is inside?

• The Price-Cost Paradox: Pressure is building on all sides, with inflation and demand for lower costs rising. There will be an impact on R&D and investment.
• A New Era of Healthcare: As new advancements in the identification of disease, treatment and even cures continue, companies are learning they need to keep pace with that progress or risk setbacks.
• Companies need to invest to keep pace: new technologies around AI, robotics, automation and predictive analytics create efficiencies while lowering costs.
• Flexibility is key: Companies that adapt flexibility as part of their strategy are better positioned to contain costs, compete in the market and scale manufacturing
• Continuous Manufacturing is leading the way: Moving away from batch manufacturing is providing flexibility and accelerating time to market, and allows for swift response as demands change.